Use of extrusion-spheronization to develop: Controlled-release dosage forms for diltiazem hydrochlorideSOOD, Anurag; ASHOKRAJ, Yasvanth; PANCHAGNULA, Ramesh et al.Pharmaceutical technology (2003). 2004, Vol 28, Num 4, pp 62-85, issn 1543-2521, 16 p.Article

The effect of diltiazem on coronary flow reserve in humansROSSEN, J. D; SIMONETTI, I; MARCUS, M. L et al.Circulation (New York, N.Y.). 1989, Vol 80, Num 5, pp 1240-1246, issn 0009-7322, 7 p.Article

Synthesis of thieno[3,4-c] and thieno[3,2-c][2,1]benzothiazepinesVEGA, S; DIAZ, J. A.Journal of heterocyclic chemistry. 1993, Vol 30, Num 6, pp 1509-1512, issn 0022-152XArticle

The synthesis of a conformationally rigid calcium channel blockerBARRISH, J. C; SPERGE, S. H; MORELAND, S et al.Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 1, pp 95-98Article

Thermische [2,1,3]-Eliminierung von Methanthiol aus einem 1,5-Benzothiazepin-Derivat = Elimination thermique-2,1,3 du méthanethiol à partir d'un dérivé de benzothiazépine-1,5 = Thermal [2,1,3] elimination of methanethiol from a 1,5-benzothiazepine derivativeKAUPP, G.Chemische Berichte. 1984, Vol 117, Num 4, pp 1643-1646, issn 0009-2940Article

A new heterocyclic system: imidazo[2,1-d[]1,5-]benzothiazepine. Its synthesis from 4-amino-2,3-dihydro-1,5-benzothiazepineWALIA, J. S; WALIA, A. S; LANKIN, D. C et al.Journal of heterocyclic chemistry. 1985, Vol 22, Num 4, pp 1117-1119, issn 0022-152XArticle

Studies on the chemistry of O,N- and S,N-containing heterocycles. IV: Investigations on the nucleophilic substitution of activated 1,5-benzothiazepinesBARTSCH, H; ERKER, T.Journal of heterocyclic chemistry. 1988, Vol 25, Num 5, pp 1399-1401, issn 0022-152XArticle

General pharmacology of Ca antagonist clentiazem (TA-3090): effects on peripheral systemNARITA, H; ISHIZUKA, T; YAMAGUCHI, I et al.Yakuri to chiryo. 1992, Vol 20, Num 8, pp 137-155, issn 0386-3603Article

Competitive enzyme immunoassay for anti-ulcer agent, (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5-benzothiazepin-4(5H)-one hydrochloride (BTM-1086)ASANO, T; OKUMURA, T; HIRANO, K et al.Chemical and pharmaceutical bulletin. 1986, Vol 34, Num 10, pp 4238-4243, issn 0009-2363Article

Syndrome parkinsonien sous diltiazem = Diltiazem and parkinsonian syndromeREMBLIER, C; KASSIR, A; RICHARD, D et al.Thérapie (Paris). 2001, Vol 56, Num 1, pp 57-59, issn 0040-5957Article

Applications of Lewis acids for the efficient syntheses of diltiazem, cephems, and taxoidsHASHIYAMA, Tomiki.Medicinal research reviews (Print). 2000, Vol 20, Num 6, pp 485-501, issn 0198-6325Article

Ca²⁺-Channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamilGENDRON, Fernand-Pierre; LATOUR, Jean-Gilles; GRAVEL, Denis et al.Biochemical pharmacology. 2000, Vol 60, Num 12, pp 1959-1965, issn 0006-2952Article

Diltiazem as augmentation therapy in patients with treatment-resistant bipolar disorder : a retrospective studySILVERSTONE, P. H; BIRKETT, L.Journal of psychiatry & neuroscience. 2000, Vol 25, Num 3, pp 276-280, issn 1180-4882Article

Progress Report on the Nordic Diltiazem Study (NORDIL) : An Outcome Study in Hypertensive PatientsHEDNER, T.Blood pressure. 1999, Vol 8, Num 5-6, pp 296-299, issn 0803-7051Article

Étude de l'efficacité et de la tolérance du diltiazem LP 300 mg^* chez 2000 sujets hypertendus (seul ou associé à un inhibiteur de l'enzyme de conversion) = Study of the efficacy and safety of Diltiazem LP 300 mg in 2000 hypertensive subjects (alone or combined with an angiotensin converting enzyme inhibitor)AMAR, J; JOIRE, J. E; SALVADOR, M et al.Annales de cardiologie et d'angéiologie (Paris). 1999, Vol 48, Num 1, pp 69-75, issn 0003-3928Article

Bioequivalence assessment of two different tablet formulations of diltiazem after single and repeated doses in healthy subjectsLOFFREDA, A; MATERA, M. G; ROSSI, F et al.Current medical research and opinion. 1999, Vol 15, Num 1, pp 53-61, issn 0300-7995Article

Cardiovascular pharmacological characteristics of S-2150 : A novel dual blocker of calcium channels and α₁-adrenoceptorsIWAKI, K; NAKASHIMA, M; KISHI, M et al.Cardiovascular drug reviews (Print). 1997, Vol 15, Num 4, pp 299-313, issn 0897-5957Article

Diltiazem use in tacrolimus-treated renal transplant recipientsKOTHARI, J; NASH, M; ZALTZMAN, J et al.Journal of clinical pharmacy and therapeutics (Print). 2004, Vol 29, Num 5, pp 425-430, issn 0269-4727, 6 p.Article

Penetration of diltiazem into breast milk and its pharmacokinetics in the lactating rabbitRUEDA, S; FRAILE, L. J; BREGANTE, M. A et al.Xenobiotica (London. Print). 2002, Vol 32, Num 2, pp 119-130, issn 0049-8254Article

Quantitative structure-activity relationships of antianginal drugsGUPTA, Satya P.Progress in drug research. 2001, Vol 56, pp 121-154, issn 0071-786XArticle

Sex-related differences in the renal disposition of the acidic metabolite of clentiazem in ratHANADA, K; FUJISAWA, R; KATAOKA, R et al.Xenobiotica (London. Print). 2001, Vol 31, Num 10, pp 725-731, issn 0049-8254Article

Extractive spectrophotometric methods for determination of diltiazem HCl in pharmaceutical formulations using bromothymol blue, bromophenol blue and bromocresol greenRAHMAN, Nafisur; SYED NAJMUL HEJAZ-AZMI.Journal of pharmaceutical and biomedical analysis. 2000, Vol 24, Num 1, pp 33-41, issn 0731-7085Article

Anomalies in the dosing of diltiazemPOOL, P. E.Clinical cardiology (Mahwah, NJ). 2000, Vol 23, Num 1, pp 18-23, issn 0160-9289Article

Comparative pharmacological properties among calcium channel blockers : T-channel versus L-channel blockadeNOLL, G; LÜSCHER, T. F.Cardiology. 1998, Vol 89, pp 10-15, issn 0008-6312, SUP1Conference Paper

Fatal unintentional overdose of diltiazem with antemortem and postmortem valuesCANTRELL, F. Lee; WILLIAMS, Saralyn R.Journal of toxicology. Clinical toxicology. 2005, Vol 43, Num 6, pp 587-588, issn 0731-3810, 2 p.Article